Help: To find Illnesses or Conditions associated with a Herbal Remedy. Select a letter from A - Z of Herbal Remedies. Or Scroll lists. Or Use Search.

Kava, Kava Kava

Kava, Kavakava - Herbal Research
A WHO Organizational resource: Kave Herbal Research - FULL REPORT

Medicinal uses supported by clinical data
Short-term symptomatic treatment of mild states of anxiety or insomnia, due to nervousness, stress or tension (14-24).
Uses described in pharmacopoeias and in traditional systems of medicine
To induce relaxation, reduce weight and treat fungal infections (5).
Uses described in folk medicine, not supported by experimental or clinical data
Treatment of asthma, common cold, cystitis, gonorrhoea, headaches, menstrual irregularities, urinary infections and warts (4, 5).


4. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL, February 9, 1998 production (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services).
5. Singh YN. Kava: an overview. Journal of Ethnopharmacology, 1992, 37:13-45.
14. Emser W, Bartylla K. Verbesserung der Schlafqualität. Zur Wirkung von Kava-Extrakt WS 1490 auf das Schlafmuster bei Gesunden. Neurologie/Psychiatrie, 1991, 5:636-642.
15. Blumenthal M et al., eds. The complete German Commission E monographs. Austin, TX, American Botanical Council, 1998.
16. Johnson D et al. Neurophysiologisches Wirkprofil und Verträglichkeit von Kava-Extrakt WS 1490. Eine Pilotstudie mit randomisierter Auswertung. Neurologie/Psychiatrie, 1991, 5:349-354.
17. Kinzler E, Kromer J, Lehmann E. Wirksamkeit eines Kava-Spezialextraktes bei Patienten mit Angst-, Spannungs- und Erregungszuständen nicht-psychotischer Genese. Doppelblind-Studie gegen Plazebo über 4 Wochen. Arzneimittel-Forschung, 1991, 41:584-588.
18. Lehmann E et al. Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin - a double-blind placebo-controlled study of four weeks’ treatment. Phytomedicine, 1996, 3:113-119.
19. Schulz V, Hübner W-D, Ploch M. Clinical trials with phyto-psychopharmacological agents. Phytomedicine, 1997, 4:379-387.
20. Siegers SP et al. Ergebnisse der Anwendungsbeobachtung L 1090 mit Laitan Kapseln. Ärztliche Forschung, 1992, 39:6-11.
21. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders - a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry, 1997, 30:1-5.
22. Warnecke G et al. Wirksamkeit von Kawa-Kawa-Extrakt beim klimakterischen Syndrom. Klinische Wirksamkeit und Verträglichkeit von Kawa-Extrakt WS 1490. Zeitschrift für Phytotherapie, 1990, 11:81-86.
23. Warnecke G. Psychosomatische Dysfunktionen im weiblichen Klimakterium. Fortschritte der Medizin, 1991, 109:119-122.
24. Woelk H et al. Behandlung von Angst-Patienten. Zeitschrift für Allgemeine Medizin, 1993, 69:271-277.

Health Issues

An international team of researchers from Brazil, the United States and Sweden has found that polyphenols found in berries of the açaí palm (Euterpe oleracea)


What we know so far about who’s at risk for COVID-19—and why the government isn’t doing more to protect us.
Alliance for natural Health USA


Over the last few weeks, the alliance for natural health has been reporting on promising natural options for preventing and treating COVID-19 infection.